Company Overview

Update
Founded:
2004
Founders:
Michael Tobias Stumpp
Headquarters:
Zürich
Funding:
$59.80M
Categories:
Biotechnology

Molecular Partners focuses on therapeutic, diagnostic, and biotechnological applications of designed ankyrin repeat proteins.

Description

Update

Molecular Partners AG, a biotechnology company, engages in the discovery and development of Designed Ankyrin Repeat Proteins (DARPins) based on the designed repeat protein technology. The company focuses on therapeutic, diagnostic, and biotechnological applications of DARPins. DARPins are binding proteins that show activity against various disease targets, including cell surface receptors, cytokines, proteases, kinases, and viral coat proteins. The company was incorporated in 2004 and is based in Zurich, Switzerland.

Current Team (4)

Update

Board Members and Advisors (7)

Update

Funding Rounds (2) - $59.80M

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Wagistrasse 14

    Zürich-Schlieren

    Zürich, 8952

    CHE

Images (1)

Update
  • A18d4b942af71cc54c8fabf2c497c8d8